id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338359-pd4bfjet	Yu, J.	Risk assessment of admission procedures for cancer patients during the convalescence of COVID-19	2020-09-30		.txt	text/plain	1094	74	49	Conclusions: Unbiased proteomic profiling of COVID-19 patient serum identified a panel of candidate protein biomarkers that associate with tocilizumab treatment response as well as the ensuing course of the disease. Background: There are limited data on cancer patients (pts) and the novel coronavirus (SARS-CoV2) respiratory disease (COVID-19). We aim to evaluate the frequency of ILI in cancer pts during the pandemic, and to identify high-risk subjects to test for COVID-19. Results: Overall, 562 pts were enrolled: 13 (2%) pts had a positive SARS-CoV2 swab, none of which performed on the basis of triage procedures or questionnaires, rather detected through telephone communications and triage; 52 (9%) pts reported suspect symptoms and/or laboratory tests. The incidence of both COVID-19 diagnosis (2%), and SARS-CoV2 Ab positivity in pts tested on the basis of suspect symptoms (<1%), were similar to those observed in the general population.	./cache/cord-338359-pd4bfjet.txt	./txt/cord-338359-pd4bfjet.txt